AwardTape · Defense awards · Medical · Drugs and biologicals · N6328522FA021
N6328522FA021: -$4.6K BPA call to Emergent Devices, Inc
Emergent Devices, Inc holds a BPA call from Department of the Navy with -$4.6K obligated since Oct 2023 and $0 obligated over its life. Latest action Mar 4, 2024.
Narcan nasal spray
| PIID | N6328522FA021 |
|---|---|
| Type | BPA call |
| Parent award | N6328522AA003 |
| Company | Emergent Devices, Inc |
| Agency | Department of the Navy |
| Contracting office | NCIS QUANTICO VA |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325411 MEDICINAL AND BOTANICAL MANUFACTURING |
| Obligated since Oct 2023 | -$4.6K |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $0 |
| Base date | Mar 7, 2022 |
| Latest action | Mar 4, 2024 |
| End date | Oct 5, 2022 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | VA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial